| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
-Aminocaproic Acid with Postoperative Decrease in Creatinine Clearance in 1502 Coronary Bypass Patients
Departments of Anesthesiology
* and Medicine (Division of Nephrology)
, Duke University Medical Center, Durham, North Carolina
Address correspondence and reprint requests to Mark Stafford Smith, FRCPC, Department of Anesthesia, Box 3094, Duke University Medical Center, Durham, NC 27710. Address e-mail to staff002{at}mc.duke.edu
Renal dysfunction is a common serious complication after cardiac surgery. Reports of proteinuria and hyperkalemia after cardiac surgery with 
-aminocaproic acid (EACA) have therefore raised concerns for renal safety. Since EACA renders these markers unreliable, we used perioperative change in creatinine clearance (DCrCl) to test the hypothesis that EACA is associated with greater reductions in creatinine clearance after heart surgery, particularly for patients with renal disease. We evaluated data from all elective primary coronary bypass patients during EACA introduction at our institution (July 1, 1991–December 31, 1992; 10 g iv bolus pre-cardiopulmonary bypass, then 1 g/h for 5 h). DCrCl was calculated using preoperative (CrPre) and postoperative peak serum creatinine values, using the Cockroft-Gault equation. Patients with CrPre 
133 µmol/L were also separately analyzed. Evaluated patients (n = 1502, ±EACA; 581/905, 16 exclusions) included 233 with CrPre 133 µmol/L (±EACA; 98/135). Multivariate analyses confirmed several known risk factors, but no association between DCrCl and EACA in all patients (P = 0.66), and the subgroup with CrPre 133 µmol/L (P = 0.42).
Implications: In a large population of primary Coronary Artery Bypass Graft including a subset with preoperative renal dysfunction, there were no postoperative reductions in creatinine clearance attributable to -aminocaproic (EACA) administration. This retrospective study suggests that moderate -aminocaproic acid dosing during cardiac surgery is safe for the kidney; however, this inference is based on a single marker of renal dysfunction and requires prospective confirmation using a variety of tests of renal function.
This article has been cited by other articles:
|
|
 |
|
  M. Stafford-Smith Evidence-Based Renal Protection in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2005; 9(1): 65 - 76. [Abstract] [PDF]
|
|
|
|
 |
|
 B. J. McCreath, M. Swaminathan, J. V. Booth, B. Phillips-Bute, S. T.H. Chew, D. D. Glower, and M. Stafford-Smith Mitral valve surgery and acute renal injury: port access versus median sternotomy Ann. Thorac. Surg., March 1, 2003; 75(3): 812 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Swaminathan, B. J. McCreath, B. G. Phillips-Bute, M. F. Newman, J. P. Mathew, P. K. Smith, J. A. Blumenthal, and M. Stafford-Smith Serum Creatinine Patterns in Coronary Bypass Surgery Patients With and Without Postoperative Cognitive Dysfunction Anesth. Analg., July 1, 2002; 95(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Butterworth, R. L. James, Y. A. Lin, J. Bennett, and R. C. Prielipp Gender Does Not Influence Epsilon-Aminocaproic Acid Concentrations in Adults Undergoing Cardiopulmonary Bypass Anesth. Analg., June 1, 2001; 92(6): 1384 - 1390. [Abstract] [Full Text] [PDF]
|
|
|
